Strategic Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.1M Sell
3,582
-512
-13% -$159K 0.23% 71
2026
Q2
$1.15M Buy
4,094
+19
+0.5% +$5K 0.25% 68
2026
Q1
$1.09M Sell
4,075
-7
-0.2% -$1.9K 0.18% 97
2025
Q4
$1.02M Buy
4,082
+1,683
+70% +$447K 0.16% 103
2025
Q3
$689K Buy
2,399
+242
+11% +$64.8K 0.11% 123
2025
Q2
$566K Buy
+2,157
New +$525K 0.11% 111

Other funds holding LH

Strategic Advisors's LH Position: Q3 2026 in Review

Strategic Advisors reduced its Labcorp (LH) stake by 13% in Q3 2026, selling an estimated $159K and leaving 3,582 shares worth $1.1M. The position accounts for 0.23% of the portfolio, ranked #71.

Strategic Advisors first reported a position in LH in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.15M in Q2 2026. 1,095 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Strategic Advisors held 3,582 shares of Labcorp worth $1.1M as of Q3 2026.
  • Strategic Advisors sold 512 Labcorp shares in Q3 2026, an estimated $159K.
  • Labcorp made up 0.23% of Strategic Advisors's portfolio in Q3 2026, its #71 holding.
  • Strategic Advisors first reported a position in Labcorp in Q2 2025 and has held it in 6 quarters since.
  • Strategic Advisors's Labcorp position peaked at $1.15M in Q2 2026.
  • 1,095 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Strategic Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.